ClinChoice puts patients at the center of all clinical development activities. To accelerate clinical development and facilitate patient engagement and retention, ClinChoice applies custom decentralized clinical trial (DCT) and hybrid strategies meticulously crafted to address the unique challenges of each study. The use of DCT and Digitalized Health Technologies (DHT) makes studies more inclusive, involving community-based sites and facilitating the inclusion of members of minority groups, older individuals, and people with disabilities, for example. With the use of leading technology, study results are more representative of population diversity.
Our versatile DCT capabilities, spanning various therapeutic areas, guarantee study management within defined timelines and budgets. Leveraging cutting-edge technologies such as electronic consent, ePROs, telehealth, and device integrations, we facilitate patient participation in clinical trials, bringing their essence to the comfort of participants’ homes.
